{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Rezolute, Inc."},"Symbol":{"label":"Symbol","value":"RZLT"},"Address":{"label":"Address","value":"201 REDWOOD SHORES PARKWAY,SUITE 315, REDWOOD CITY, California, 94065, United States"},"Phone":{"label":"Phone","value":"+1 650 206-4507"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402."},"CompanyUrl":{"label":"Company Url","value":"https://www.rezolutebio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Brain Roberts","title":"Chief Medical Officer"},{"name":"Nevan Charles Elam","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}